I
Irl B. Hirsch
Researcher at University of Washington
Publications - 388
Citations - 27882
Irl B. Hirsch is an academic researcher from University of Washington. The author has contributed to research in topics: Diabetes mellitus & Insulin. The author has an hindex of 75, co-authored 336 publications receiving 23406 citations. Previous affiliations of Irl B. Hirsch include American Diabetes Association & University of Washington Medical Center.
Papers
More filters
Journal ArticleDOI
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino,Thomas Danne,Richard M. Bergenstal,Stephanie A. Amiel,Roy W. Beck,Torben Biester,Emanuele Bosi,Bruce A. Buckingham,William T. Cefalu,Kelly L. Close,Claudio Cobelli,Eyal Dassau,J. Hans DeVries,Kim C. Donaghue,Klemen Dovc,Francis J. Doyle,Satish K. Garg,George Grunberger,Simon Heller,Lutz Heinemann,Irl B. Hirsch,Roman Hovorka,Weiping Jia,Olga Kordonouri,Boris Kovatchev,Aaron J. Kowalski,Lori M. Laffel,Brian J. Levine,Alexander Mayorov,Chantal Mathieu,Helen R. Murphy,Revital Nimri,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,David Rodbard,Banshi Saboo,Desmond A. Schatz,Keaton C. Stoner,Tatsuiko Urakami,Stuart A. Weinzimer,Moshe Phillip,Moshe Phillip +42 more
TL;DR: This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Journal ArticleDOI
Continuous glucose monitoring and intensive treatment of type 1 diabetes.
William V. Tamborlane,Roy W. Beck,Bruce W. Bode,Bruce A. Buckingham,Chase Hp,Robert Clemons,Rosanna Fiallo-Scharer,Larry A. Fox,Lisa K. Gilliam,Irl B. Hirsch,Elbert S. Huang,Kollman C,Kowalski Aj,Lori M.B. Laffel,Jean M. Lawrence,Joyce M. Lee,Nelly Mauras,Michael J. O'Grady,Katrina J. Ruedy,Michael Tansey,Eva Tsalikian,Stuart A. Weinzimer,Darrell M. Wilson,Howard Wolpert,T. Wysocki,Dongyuan Xing +25 more
TL;DR: Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes and further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents.
Journal ArticleDOI
Management of diabetes and hyperglycemia in hospitals.
Stephen Clement,Susan S. Braithwaite,Michelle F. Magee,Andrew J. Ahmann,Elizabeth P. Smith,Rebecca G. Schafer,Irl B. Hirsch +6 more
TL;DR: The purpose of this technical review is to evaluate the evidence relating to the management of hyperglycemia in hospitals, with particular focus on the issue of glycemic control and its possible impact on hospital outcomes.
Journal ArticleDOI
Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
Maryam Afkarian,Michael C. Sachs,Bryan Kestenbaum,Irl B. Hirsch,Katherine R. Tuttle,Jonathan Himmelfarb,Ian H. de Boer +6 more
TL;DR: Those with kidney disease predominantly account for the increased mortality observed in type 2 diabetes, and similar patterns for cardiovascular and noncardiovascular mortality are observed.
Journal ArticleDOI
Role of Orlistat in the Treatment of Obese Patients With Type 2 Diabetes: A 1-year randomized double-blind study
Priscilla Hollander,Steven C. Elbein,Irl B. Hirsch,David E. Kelley,Janet B. McGill,Terry Taylor,Stuart R Weiss,Samuel E Crockett,Roy Kaplan,John Comstock,Charles P. Lucas,Peter A Lodewick,William Canovatchel,Jain Chung,Jonathan Hauptman +14 more
TL;DR: Orlistat is an effective treatment modality in obese patients with type 2 diabetes with respect to clinically meaningful weight loss and maintenance of weight loss, improved glycemic control, and improved lipid profile.